Clinical Trials Directory

Trials / Conditions / Shigella

Shigella

10 registered clinical trials studyying Shigella — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingThe Impact of Shigellosis and Recommended Treatment in Children
NCT07433426
Johns Hopkins Bloomberg School of Public HealthPhase 2
RecruitingFirst in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in
NCT07205926
Inventprise Inc.Phase 1
RecruitingSafety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and E
NCT07049159
Eveliqure Biotechnologies GmbHPhase 2
Active Not RecruitingEnterics for Global Health (EFGH)
NCT06047821
University of Washington—
CompletedShigella CVD 30000: Study of Responses to Vaccination With Shigella Vaccine
NCT04078022
University of Maryland, BaltimorePhase 2
UnknownMultidrug Resistant Shigella Infection in Bangladesh
NCT03778125
University of Virginia—
CompletedSafety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection Using cG
NCT01531530
University of Maryland, BaltimorePhase 1
CompletedSafety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine Candidate
NCT01080716
U.S. Army Medical Research and Development CommandPhase 1 / Phase 2
TerminatedSafety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection: Phase I
NCT00866476
University of Maryland, BaltimorePhase 2
TerminatedSafety and Efficacy Challenge Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella: Phase I
NCT00866242
University of Maryland, BaltimorePhase 2